FBLG
FibroBiologics, Inc. Common Stock
There isn't enough reported data to score FBLG yet.
FBLG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
FBLG's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
FBLG PE Valuation
FBLG has no meaningful PE right now: it lost money over the past year.
FBLG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| -- | |
| -- | |
| Limited | |
| High |
Analysts expect FBLG's losses to shrink, with revenue holding steady.
FBLG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$5.19 | +$2.01 |
| Q1 2026 | -$6.93 | -$2.73 |
| Q4 2025 | -$8.40 | -$1.60 |
| Q3 2025 | -$9.60 | +$1.60 |
| Q2 2025 | -$7.20 | +$5.15 |
| Q1 2025 | -$4.20 | +$10.08 |
| Q4 2024 | -$6.80 | +$5.08 |
| Q3 2024 | -$11.20 | -$4.52 |
FBLG is still losing money, but far less than before: $5.19 per share over the past year, against $14.28 at its worst in early 2024.
FBLG Quarterly Revenue
FBLG's revenue is shrinking: $0 last quarter.
FBLG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.3M | +$906K |
| Q1 2026 | -$4.4M | +$954K |
| Q4 2025 | -$3.2M | +$9K |
| Q3 2025 | -$4M | -$1.4M |
| Q2 2025 | -$4.2M | -$2.2M |
| Q1 2025 | -$5.3M | -$1M |
| Q4 2024 | -$3.2M | -$1.6M |
| Q3 2024 | -$2.6M | -$1.1M |
FBLG has burned cash in almost every quarter: −$15M over the past year, against −$15M the year before.
FBLG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +66% | +2.5M shares |
| 1 year | +242% | +4.4M shares |
| 3 years | +286% | +4.6M shares |
FBLG has 6M diluted shares, up 242% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
FBLG Net Leverage
FBLG's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
FBLG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.7 | Neutral |
| Stochastic | 14.6 | Oversold |
FBLG's weekly RSI is 37 (neutral) and its Stochastic is 15 (oversold).
FBLG PE vs Healthcare Sector
FBLG has no meaningful PE right now: it lost money over the past year.
FBLG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.07 | 9.3% below |
| 20 week MA | $1.12 | 13% below |
| 50 week MA | $2.78 | 65% below |
| 100 week MA | $10.7 | 91% below |
FBLG is in a downtrend: it's below all four of its weekly moving averages, and 91% below its 100-week average.
FBLG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $300.0 | $47.2 | -84% |
| 2025 | $47.2 | $4.98 | -89% |
| 2026 YTD | $4.98 | $0.97 | -81% |
FBLG has finished every year since 2024 lower, and it's down 81% so far in 2026.